Edge Therapeutics Announces Pricing of Its Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Edge Therapeutics (EDGE) IPO Prices at $11, Well Below Expected Range
October 1, 2015 9:42 AM EDTEdge Therapeutics, Inc. (Nasdaq: EDGE) announced the pricing of its initial public offering of 7,315,151 shares of its common stock at a public offering price of $11.00 per share, below the expected $14-$16 range. The IPO size was raised from 5.67 million. The shares are... More
